C. Tan

A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells

Q. Sun, F. Liu, B. Chu, 2015, Cell Death and Disease.

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis

J. Zha, M. J. C. Ludlam, D. Kallop, 2009, Oncogene.

Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma

A. Ebens, T. Januario, S. Prabhu, 2010, Leukemia.

LPS expands MDSCs by inhibiting apoptosis through the regulation of the GATA2/let‐7e axis

Zhengrong Chen, Chuangli Hao, Jinping Zhang, 2018, Immunology and cell biology.

282 Bispecific antibodies (BsAbs) targeting ABCB1/PgP and CD47 provide a multi-modal, tumor specific approach to combat drug resistant cancers

L. Presta, P. Klein, Jessica A. Morgan, 2021, Journal for ImmunoTherapy of Cancer.